Driver mutations, like the mutation of the epidermal growth factor receptor (EGFR) gene, prevalent in 48% of Asian and 19% of Western LUAD patients, play a crucial role in tumor growth and invasiveness [3]. This evidence concerns the gene EGFR and neoplasm.